$6.16
0.437.50%
al cierre: -
$6.10
-0.06-0.97%
After hour: 7:53 PM EDT
Corvus Pharma informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Analice el historial de beneficios de Corvus Pharma utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
CRVS | Corvus Pharma | -$0.60 | -$0.13 | — | — | $0.00 | — | — | — | 11/11/2025 | |
CRVS | Corvus Pharma | -$0.07 | -$0.13 | -$0.10 | 23.08% | $0.00 | — | $0.00 | — | 08/07/2025 | |
CRVS | Corvus Pharma | -$0.12 | -$0.12 | -$0.13 | -8.33% | $0.00 | — | $0.00 | — | 05/08/2025 | |
CRVS | Corvus Pharma | -$0.14 | -$0.12 | -$0.18 | -50.00% | $0.00 | — | $0.00 | — | 03/25/2025 | |
CRVS | Corvus Pharma | -$0.12 | -$0.11 | -$0.60 | -445.45% | $0.00 | — | $0.00 | — | 11/12/2024 | |
CRVS | Corvus Pharma | -$0.14 | -$0.12 | -$0.07 | 41.67% | $0.00 | — | $0.00 | — | 08/06/2024 | |
CRVS | Corvus Pharma | -$0.17 | -$0.11 | -$0.12 | -9.09% | $0.00 | — | $0.00 | — | 05/06/2024 | |
CRVS | Corvus Pharma | -$0.21 | -$0.12 | -$0.14 | -16.67% | $0.00 | — | $0.00 | — | 03/19/2024 | |
CRVS | Corvus Pharma | -$0.32 | -$0.12 | -$0.12 | 0.00% | $0.00 | — | $0.00 | — | 11/07/2023 | |
CRVS | Corvus Pharma | -$0.18 | -$0.14 | -$0.14 | 0.00% | $0.00 | — | $0.00 | — | 08/08/2023 | |
CRVS | Corvus Pharma | -$0.18 | -$0.16 | -$0.17 | -6.25% | $0.00 | — | $0.00 | — | 05/08/2023 | |
CRVS | Corvus Pharma | -$0.20 | -$0.23 | -$0.21 | 8.70% | $0.00 | — | $0.00 | — | 03/28/2023 | |
CRVS | Corvus Pharma | -$0.24 | -$0.16 | -$0.32 | -100.00% | $0.00 | — | $0.00 | — | 11/03/2022 | |
CRVS | Corvus Pharma | -$0.28 | -$0.18 | -$0.18 | 0.00% | $0.00 | — | $0.00 | — | 08/08/2022 | |
CRVS | Corvus Pharma | -$0.34 | -$0.15 | -$0.18 | -20.00% | $0.00 | — | $0.00 | — | 05/05/2022 | |
CRVS | Corvus Pharma | -$0.34 | -$0.19 | -$0.20 | -5.26% | $0.00 | — | $0.00 | — | 03/10/2022 | |
CRVS | Corvus Pharma | -$0.33 | -$0.26 | -$0.24 | 7.69% | $0.00 | — | $0.00 | — | 11/01/2021 | |
CRVS | Corvus Pharma | -$0.36 | -$0.34 | -$0.28 | 17.65% | $0.00 | — | $0.00 | — | 08/02/2021 | |
CRVS | Corvus Pharma | -$0.44 | -$0.31 | -$0.34 | -9.68% | $0.00 | — | $0.00 | — | 04/29/2021 | |
CRVS | Corvus Pharma | -$0.38 | -$0.32 | -$0.34 | -6.25% | $0.00 | — | $0.00 | — | 03/25/2021 | |
CRVS | Corvus Pharma | -$0.37 | -$0.24 | -$0.33 | -37.50% | $0.00 | — | $0.00 | — | 10/29/2020 |
Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
---|---|---|---|---|
Q2 | 2025-08-07 | $-0.10 | $-0.13 | 23.1 % |
Q1 | 2025-05-08 | $-0.13 | $-0.12 | -8.33 % |
Q4 | 2025-03-25 | $-0.18 | $-0.12 | -50.0 % |
Q3 | 2024-11-12 | $-0.60 | $-0.11 | -445.5 % |
Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
---|---|---|---|---|
Está previsto que Corvus Pharma (CRVS) presente resultados el noviembre 11, 2025. Los últimos resultados se publicaron el agosto 7, 2025 para el Q2.
El BPA real fue de $-0.10, que superó la estimación de $-0.13.
Los ingresos reales fueron $0K, que alcanzó la estimación de $0K.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.